FDA

FDA approves Roche therapy for bladder cancer
Marketwatch
Thu, 05/19/16 - 09:55 am
FDA
Roche
bladder cancer
Tecentriq
atezolizumab
Bristol-Myers extends lead with new Opdivo indication
BioPharma Dive
Tue, 05/17/16 - 05:20 pm
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Sarepta's AdCom Needs FDA's Permission To Speak Freely
Forbes
Mon, 05/16/16 - 11:55 am
Sarepta Therapeutics
FDA
eteplirsen
Allergan’s Occuleve on track for FDA submission this year
Mass Device
Mon, 05/16/16 - 11:48 am
Allergan
Occuleve
devices
FDA
dry eye disease
nasal neurostimulation
Pharma, The FDA, And Social Media
Forbes
Mon, 05/16/16 - 10:01 am
FDA
social media
FDA releases draft guidance on 3D-printed medical devices
Mass Device
Sat, 05/14/16 - 12:55 pm
FDA
devices
3D printing
3D-printed medical devices
Why an FDA plan to find compassionate-use drugs may be a Band-Aid
Stat
Sat, 05/14/16 - 12:46 pm
FDA
compassionate use guidelines
FDA approves Biofrontera’s drug-device combo for sun-induced skin cancer
Mass Device
Fri, 05/13/16 - 10:36 am
FDA
Biofrontera
devices
skin cancer
Ameluz
BF-RhodoLED
After shutting down cancer drug, Clovis now facing government investigations
BioPharma Dive
Fri, 05/13/16 - 10:15 am
Clovis Oncology
rociletinib
FDA
3 Risky Biotechs With FDA Decisions On Deck
Motley Fool
Fri, 05/13/16 - 10:08 am
FDA
Sarepta Therapeutics
eteplirsen
Synergy Pharmaceuticals
plecanatide
Celator
Vyxeos
Sanofi R&D chief, ex-FDA head cite need to improve international regulatory coordination
BioPharma Dive
Fri, 05/13/16 - 09:56 am
Sanofi
R&D
FDA
Margaret Hamburg
regulatory
​Chiasma CEO says company may challenge FDA over rare-disease drug rejection
Bizjournals.com
Thu, 05/12/16 - 09:46 am
Chiasma
FDA
Mycapssa
acromegaly
FDA wants drug makers to pay fees to review OTC medicines
Stat
Wed, 05/11/16 - 06:38 pm
FDA
OTC
consumer health
​Hopes rise for FDA approval of Zafgen’s fat-busting drug among analysts, investors
Bizjournals.com
Wed, 05/11/16 - 06:35 pm
FDA
Zafgen
FDA flags safety risks for Lilly antipsychotic drug
BioPharma Dive
Tue, 05/10/16 - 03:06 pm
FDA
Eli Lilly
antipsychotics
Symbyax
Zyprexa
Olanzapine
FDA should listen to patients, not just clinical trial data, on rare disease therapies
Stat
Tue, 05/10/16 - 09:42 am
Marco Rubio
FDA
orphan diseasese
Rare Diseases
patients
Theravance Gets FDA Nod on Vibativ
24/7 Wall St
Mon, 05/9/16 - 10:42 am
Theravance
FDA
Vibativ
SAB
antibiotics
The FDA Should Remove Warning Label On The Smoking Cessation Drug Chantix
Forbes
Thu, 05/5/16 - 10:04 am
FDA
warnings
Pfizer
Chantix
smoking cessation
Panel: Painkiller training should be required for physicians
Yahoo/AP
Wed, 05/4/16 - 06:47 pm
painkillers
physicians
FDA
opioids
Generic drug backlog persists as FDA slowly clears applications
BioPharma Dive
Wed, 05/4/16 - 06:42 pm
FDA
generics

Pages